SIM
KYNB icon

Strategic Investment Management’s Kyntra Bio KYNB Stock Holding History

Strategic Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-456
Closed -$187K – 109
2016
Q2 		$187K Buy
+456
New +$209K 0.1% 71

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Waddell & Reed Financial
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Janus Henderson Investors US
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Strategic Investment Management's KYNB Position: Q3 2016 in Review

Strategic Investment Management sold out of Kyntra Bio (KYNB) in Q3 2016, closing a stake of 456 shares — an estimated $187K sold.

Strategic Investment Management first reported a position in KYNB in Q2 2016 and held it in 1 quarter. The position peaked at $187K in Q2 2016. 133 funds tracked by Wall St. Rank hold KYNB as of Q3 2016.

  • Strategic Investment Management reported no remaining Kyntra Bio position as of Q3 2016 after selling out during the quarter.
  • Strategic Investment Management sold 456 Kyntra Bio shares in Q3 2016, an estimated $187K.
  • Strategic Investment Management first reported a position in Kyntra Bio in Q2 2016 and held it in 1 quarter.
  • Strategic Investment Management's Kyntra Bio position peaked at $187K in Q2 2016.
  • 133 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2016.

Based on Strategic Investment Management's 13F filing for Q3 2016, filed 15 Nov 2016.